Jan 21, 2026 06:10AM
Dec 29, 2025 11:25AM
Dec 26, 2025 06:41AM
Dec 11, 2025 08:04AM
Nov 20, 2025 04:01PM
Nov 20, 2025 04:01PM
Mar 31, 2025 06:45AM H.C. Wainwright Reiterates Neutral Rating on Inhibikase Therapeutics Inc (IKT)
Nov 14, 2024 08:37AM
Oct 21, 2024 09:05AM
Aug 14, 2024 04:25PM
Jun 17, 2024 08:05AM
Jun 5, 2024 08:05AM
May 20, 2024 08:01AM
May 20, 2024 08:01AM Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $4.0 Million
May 15, 2024 08:00PM
May 15, 2024 08:45AM
May 15, 2024 08:45AM
May 9, 2024 08:00AM
Apr 18, 2024 04:30PM
Apr 18, 2024 04:30PM
Apr 3, 2024 08:05AM Inhibikase Therapeutics (IKT) Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension
Apr 3, 2024 08:05AM
Mar 27, 2024 04:15PM
Feb 28, 2024 04:06PM
Feb 28, 2024 04:05PM
Feb 7, 2024 07:55AM
Feb 7, 2024 07:55AM
Dec 19, 2023 08:31AM Inhibikase Therapeutics (IKT) Issues Letter to Shareholders and Provides Update on Development Programs
Dec 19, 2023 08:30AM
Dec 4, 2023 08:35AM
Dec 4, 2023 08:35AM
Nov 14, 2023 04:30PM
Oct 16, 2023 07:07AM
Oct 16, 2023 07:00AM
Oct 4, 2023 08:31AM Inhibikase Therapeutics (IKT) Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy
Oct 4, 2023 08:30AM
Aug 17, 2023 08:32AM
Aug 17, 2023 08:30AM
Aug 14, 2023 04:20PM
Jun 22, 2023 08:06AM
Jun 22, 2023 08:05AM
May 15, 2023 08:30AM Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity
Apr 26, 2023 08:04AM
Apr 26, 2023 08:00AM
Mar 31, 2023 08:22AM
Mar 15, 2023 08:35AM
Mar 15, 2023 08:35AM
Mar 8, 2023 08:35AM
Mar 8, 2023 08:30AM Inhibikase Therapeutics Announces FDA has Lifted the Full Clinical Hold on IkT-148009 in Multiple System Atrophy
Jan 27, 2023 04:05PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All